Cardiologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Chiropractor providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dentist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dermatologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Family Physician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
OB-GYN providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Ophthalmologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Orthopedic Surgeon providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Pediatrician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Physical Therapist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Podiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Psychiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Vijay Swarup, MD, FACC, FHRS, is one of the physicians at Arizona Heart Rhythm Center, which has locations in Phoenix, Peoria, Gilbert, and Prescott, Arizona. He has been practicing clinical cardiac electrophysiology in Arizona since 2002. Before joining the practice, he completed a fellowship in clinical cardiac electrophysiology at the University of Chicago Hospitals and Loyola University Medical Center in Chicago, Illinois.
Dr. Swarup earned his bachelor's and medical degrees at the University of Delhi in New Delhi. He continued his education at St. Louis University School of Medicine, completing an internal medicine residency and a research fellowship in molecular cardiology. He completed a Cardiovascular Disease fellowship at the Thomas Jefferson University Hospital in Philadelphia. He then pursued a clinical cardiac electrophysiology fellowship at the University of Chicago Hospitals and Loyola University Medical Center in Chicago, Illinois.
Dr. Swarup has received specialized training in performing complex arrhythmia treatments, including trans-catheter ablations. He has a special interest in three-dimensional electroanatomical mapping techniques, left atrial appendage occlusion techniques, and ablative therapies for atrial fibrillation and ventricular tachycardia.
In Arizona, Dr. Swarup was among the first to perform epicardial and endocardial 3D mapping guided ablation of ischemic ventricular tachycardias, open irrigated ablations, robotic catheter ablations for arrhythmias, and implantation to left atrial appendage occlusion devices. Dr. Swarup has some of the most extensive experience in AF and VT ablations and implantation of LAA occlusion devices in the country. Dr. Swarup is also an active researcher of new ablation techniques, having authored numerous abstracts and manuscripts. He has been the principal investigator in many research protocols investigating promising new ablation techniques and devices for the treatment of arrhythmias.
Dr. Swarup is board certified in cardiovascular diseases and clinical cardiac electrophysiology.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Mohammad Nasser, MD, founder of Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona, is a board-certified internal medicine physician and population health specialist. Dr. Nasser has a special interest in complex patient care, gaining extensive experience as a hospitalist and internist providing care in hospitals, long-term acute care centers, and subacute rehabilitation.
With a well-known reputation as an exceptional health care innovator, Dr. Nasser creates and implements programs that improve the quality of care and diminish costs for hospitals and skilled nursing facilities.
Born and raised in Michigan, Dr. Nasser received his bachelor’s degree from Wayne State University in Detroit Michigan. After receiving his medical degree at the American University of the Caribbean School of Medicine in Sint Maarten, he completed his internship and internal medicine residency at Ascension Providence Hospital, Michigan State University College of Human Medicine in Grand Rapids, Michigan.
Dr. Nasser is known for numerous accomplishments in his field. He was the medical director at Arkos Health and managed more than 200,000 patients through his transitional care management program.
During his tenure at Arkos Health, Dr. Nasser developed an inpatient program that shortened hospital stays and mobilized patients to the next level of care. He also implemented a skilled nursing program that improved the post-discharge process.
As a respected author, Dr. Nasser published articles in medical journals as well as the well-known book, “Management of Chronic Kidney Disease.” He also served as a manuscript reviewer for medical journals, including the Journal of the American College of Cardiology.
Dr. Nasser is a proud member of the Phoenix community, where he welcomes patients and is highly regarded for his quality of care and leadership roles.
Board-certified internal medicine physician, William Nassour, MD, provides integrative health care at Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona. His expertise includes all aspects of adult health care, however, he has a special interest in cardiovascular disease, diabetes, geriatrics, and post-acute care.
Dr. Nassour is well-respected for go-to advice, with peers seeking his assistance and guidance in geriatrics and post-acute care, and patients depending on his understanding to provide honest evaluations and recommend individualized care.
Dr. Nassour received his medical degree from Tishreen University in Latakia, Syria, and completed his residency training in internal medicine at the New York University Langone Health in Brooklyn, New York.
With more than a decade of experience as a practicing physician in hospital medicine, including outpatient and subacute care, Dr. Nassour has developed extensive knowledge and skills that help him better understand each patient and create effective treatment plans.
He has successfully filled leadership roles as the medical director in different medical settings. He also remains active on various hospital committees.
Dr. Nassour welcomes new and current patients at Leading MDs, where he collaborates with each person to improve their health and well-being.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Leon Thompson, DO, is an experienced internal medicine physician at Thompson Medical Group in Peoria, Arizona. He provides comprehensive care to adults of all ages living with conditions ranging from heart disease and diabetes to memory loss. He supports people with personalized chronic disease management and weight management programs.
Dr. Thompson is a native of Arizona. He attended St. Matthew Catholic School in Phoenix, Arizona, and graduated from St. Mary’s Catholic High School, also in Phoenix. Dr. Thompson completed his undergraduate studies at Arizona State University in Phoenix and attended medical school at the Western University of Health Sciences, College of Osteopathic Medicine of the Pacific in Pomona, California.
After graduating with a Doctorate in Osteopathic Medicine, Dr. Thompson completed his internship and residency at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. He completed an American College of Osteopathic Internists fellowship and is board-certified in internal medicine.
Dr. Thompson welcomes patients to Thompson Medical Group, where they can be sure of outstanding care delivered in a professional and respectful environment.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.
Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.
In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.
During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.
Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Stephanie Lindauer specializes in Medical Oncology, Hematology and Internal Medicine. Her clinical interests include breast cancer and benign breast disease, gastrointestinal cancer and cancer survivorship.
Dr. Lindauer joined Arizona Center for Cancer Care in 2018. She has held a variety of leadership roles. She was Chief Resident of the Department of Internal Medicine, serving an additional year after completing her residency in San Antonio. She also served as Chief Fellow during her last year of fellowship in San Antonio. Dr. Lindauer has several abstracts and poster presentations at local and national meetings, including ASCO Survivorship Symposium, ASCO Quality Care Symposium and ASH Hematologic Malignancies. She is passionate about engagement within her community and has presented at Updates for the San Antonio Community from the San Antonio Breast Cancer Symposium in 2017.
Dr. Lindauer was drawn to the field of oncology from a young age, having seen the effects of cancer in loved ones. She feels honored to be able to fulfill such an important role now and strives for compassion and empathy with all her patients.
Dr. Lindauer is a member of the American Society of Clinical Oncology and American Society of Hematology. She enjoys spending time with her husband and her chocolate lab.
"I have been seeing Dr. Lindauer for over 2 years. She came highly recommended to me by my Lymphedema Therapist. Dr. Lindauer has been very professional, compassionate and patient with me in informing me of my treatment plan for a rare form of cancer." -Vanessa
"I have been seeing Dr. Lindauer for a year now. I'm so glad my breast surgeon Dr. Naomi Sigalove recommended her. She is very compassionate about her patients. She works with all of my other Doctors to insure that I received the best possible care. She never rushed me through a visit and answered all of my questions. Her staff is awesome to. From the front desk to the treatment area. I can't tell you enough how wonderful everyone really is. I will miss everyone in the office when my treatment is over." -Mary
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Andrew J. Buresh specializes in medical oncology, hematology, and internal medicine. He is interested in all aspects of clinical oncology and hematology, with a particular interest in gastrointestinal, breast, lung, and prostate cancer, as well as myelodysplasia, coagulation disorders, lymphoma, and myeloma.
Dr. Buresh joined Arizona Center for Cancer Care in 2013 when Desert Springs Cancer Care Center, which he founded and partnered with the practice. He is a member of the American Society of Clinical Oncology, American Society of Hematology and Arizona State Physicians Association.
Dr. Buresh is a multi-year “Top Doc” honoree by Phoenix Magazine and was chosen for the cover of the annual ranking magazine in 2013. He was also honored by the Phoenix Business Journal as among its “40 Top Business Leaders under Age 40.”
Dr. Buresh and his wife are blessed to be the proud parents of three beautiful children. When not caring for patients, Dr. Buresh enjoys spending his time with family, exercising, reading, playing basketball, golf, guitar, and coaching youth sports. He also speaks basic medical Spanish.
"Warm and caring in all aspects of care. He’s special in his approach and looks at the big picture. Spends a lot of time asking questions and is conservative in his approach. So glad I was referred to him and will continue to refer him to others. Don’t be afraid~ take him on your journey with you!" -Robin
Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.
Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.
In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.
During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.
Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.
Dr. Joan Dahmer specializes in hematology, medical oncology, and internal medicine.
Dr. Dahmer joined Arizona Center for Cancer Care in 2008 when her team at Arizona Center for Hematology and Oncology partnered with the practice. Prior to joining Arizona Center for Hematology and Oncology in 2002, Dr. Dahmer developed the oncology program at both Maryvale and Memorial Hospitals in Phoenix. She was also Chief of Medicine at Laurentian Hospital in California and has served as a medical consultant for prominent centers and labs.
Dr. Dahmer has been active in the medical community as a past or current member of several organizations, most recently as a member of The Arizona Clinical Oncology Society, the American Society of Hematology, and the Association of Community Cancer Centers, to name a few.
She has also volunteered her time to many health-related causes, including serving as medical director for the HAVEN Program of Northeastern Ohio, a comprehensive program for those infected with and affected by HIV.
She has presented on a number of topics including, medical marijuana, cardiac assessment in home care to home health nurses, women in medicine, oral & lung cancer and medicine as a career.
"Dr. Dahmer is very good, kind, understanding, and very professional 👏." -Cozetta
"Virginia Piper cancer center has the nicest. Most accommodating staff and nurses. Doc Dahmer is the best doctor I have heard of. She is patient. Kind. Incredibly smart. Very thorough. I just love her. You wont be disappointed with her." -Samantha
Dr. Parmjeet Kumar Banghar specializes in hematology, medical oncology, and internal medicine. He joined Arizona Center for Cancer Care in 2008 when his team at Arizona Center for Hematology and Oncology partnered with the practice.
Currently, Dr. Banghar is a member of the American Society of Clinical Oncology and American Society of Hematology. He has participated in a research study involving cerebrovascular diseases and been published in several journals, including Leukemia Research and the Indian Journal of Medical Sciences. He has also presented on a number of topics, including sonographic evaluation of the spleen in sickle cell syndromes, lennox gastaut syndrome and sweet syndrome in a patient with acute myeloid leukemia.
"This doctor is smart and knows cancer. The staff is the best. My nurses who give me shots are the best! Highly reccomend this office." -Lina
"I have been Dr. Banghar's patient since 2019 and just found out I could give him a review. Wish I had been told this before. He is an excellent provider. He has made me feel confident about my treatment which I think has/had a tremendous amount of impact on my care and the outcome. I would recommend him and the facility in a heart beat." -Felicia
Dr. Devinder Singh obtained his MD from the Government Medical College in Patiala (Punjab), India. He completed his internship and residency in Internal Medicine from Wayne State University in Detroit, Michigan. Shortly after, he completed his fellowship in Medical Oncology and Hematology from the City of Hope National Medical Center in Duarte, California in 1992. He is board certified in Internal Medicine, Oncology, and Hematology.
In August of 1992, he founded the Arizona Center for Hematology/Oncology and has been servicing the greater Phoenix area since then with his other medical oncology associates. In 2008, in collaboration with Drs. Biggs, Lee, and Reed, the radiation oncology division was established, and the practice name was changed to Arizona Center for Cancer Care. Among his many accomplishments, in 2019 Dr. Singh received the “Oncology Service Award” from Phoenix Cancer Support Network and was nominated as “Best Doctor in Oncology” by Phoenix Magazine. He is a clinical assistant professor at Midwestern Medical University (Glendale campus) and is actively involved in teaching medical students.
Dr. Singh has been married to his wonderful wife, Randeep, since 1982. They have three beautiful children, two daughters, Raman and Rimpi, and one son, Aman, all attending different universities. They also have two Yorkshire terriers, Rusty and Musty, and a playful cat, Millie. In his free time, Dr. Singh enjoys playing golf.
"Dr Singh is by far the BEST oncologist out there!!! He is very knowledgeable and really cares for his patients!!! My hubby had stage 4 lymphoma cancer in 2005 and Dr Singh saved his life!! My hubby is still cancer free today!!!" -Kirsten
"Dr. Devinder Singh was amazing. Not only having great knowledge in treating cancer but very patient and caring when my husband and I walked this journey. Dr. Singh fought alongside us to the very end, he would call and check on my husband after treatments and procedures, his team helped with any insurance issues and approvals and we always felt very special and like we were family. Thank you so much for making this journey a little easier." -Debra
Dr. Justin Goldfarb specializes in medical oncology, internal medicine, and hematology.
Growing up in suburban Detroit, Dr. Goldfarb followed his true passion to become a hematologist and medical oncologist. A published author on topics including lymphoma and breast cancer, he is double board-certified in medical oncology and internal medicine, and fellowship-trained in hematologic disorders and solid tumors.
Dr. Goldfarb earned a bachelor’s degree from the University of Colorado at Boulder and holds a medical degree from Midwestern University in Chicago. He completed an internal medicine residency at Rush University Medical Center in Chicago, followed by a medical oncology fellowship at Baylor University Medical Center in Dallas. With academic appointments at Pritzker School of Medicine at the University of Chicago and Midwestern University, Dr. Goldfarb thoroughly enjoys teaching and mentoring medical students.
"The care I receive from Dr. Goldfarb is exceptional. He listens attentively to my concerns and he provided me with a treatment plan that yields positive results. The entire team at the clinic display a high level of professionalism and make me feel comfortable while I'm there . Nicole Lee is exceptional as well." -Christian
"Dr Goldfarb has been helping me fight lung cancer for two years and is a very caring person." -JC
/assets/images/provider/photos/2288383.jpg)
/assets/images/provider/photos/2288383.jpg)
